US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
US7101993B1
(en)
|
1990-01-11 |
2006-09-05 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides containing 2′-O-modified purines
|
US6268213B1
(en)
|
1992-06-03 |
2001-07-31 |
Richard Jude Samulski |
Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
US5869305A
(en)
|
1992-12-04 |
1999-02-09 |
The University Of Pittsburgh |
Recombinant viral vector system
|
EP0682717A4
(en)
|
1993-02-05 |
1997-04-23 |
Laporte Group Australia |
ANTI-FOAMING COMPOSITE FOR DAIRY.
|
US6972193B1
(en)
|
1993-02-12 |
2005-12-06 |
Board Of Trustees Of Leland Stanford Junior University |
Regulated transcription of targeted genes and other biological events
|
US6140120A
(en)
|
1993-02-12 |
2000-10-31 |
Board Of Trustees Of Leland Stanford Jr. University |
Regulated transcription of targeted genes and other biological events
|
US5830462A
(en)
|
1993-02-12 |
1998-11-03 |
President & Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
US5869337A
(en)
|
1993-02-12 |
1999-02-09 |
President And Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
US5834266A
(en)
|
1993-02-12 |
1998-11-10 |
President & Fellows Of Harvard College |
Regulated apoptosis
|
ATE453709T1
(de)
|
1993-02-12 |
2010-01-15 |
Univ Leland Stanford Junior |
Regulierte transkription von zielgerichteten genen und andere biologische ereignisse
|
US20020173474A1
(en)
|
1993-02-12 |
2002-11-21 |
President And Fellows Of Harvard College |
Methods & materials involving dimerization-mediated regulation of biological events
|
US6150137A
(en)
|
1994-05-27 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Immunosuppressant target proteins
|
US6476200B1
(en)
|
1994-06-27 |
2002-11-05 |
The Johns Hopkins University |
Mammalian proteins that bind to FKBP12 in a rapamycin-dependent fashion
|
US6204059B1
(en)
|
1994-06-30 |
2001-03-20 |
University Of Pittsburgh |
AAV capsid vehicles for molecular transfer
|
DE69534300T2
(de)
|
1994-08-18 |
2006-05-18 |
Ariad Gene Therapeutics, Inc., Cambridge |
Neues multimerisierendes reagenz
|
US6150527A
(en)
|
1994-08-18 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Synthetic multimerizing agents
|
US6133456A
(en)
|
1994-08-18 |
2000-10-17 |
Ariad Gene Therapeutics, Inc. |
Synthetic multimerizing agents
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
US6326166B1
(en)
|
1995-12-29 |
2001-12-04 |
Massachusetts Institute Of Technology |
Chimeric DNA-binding proteins
|
JP3817739B2
(ja)
|
1994-12-29 |
2006-09-06 |
マサチューセッツ・インスティテュート・オブ・テクノロジー |
キメラdna結合性タンパク質
|
US6166197A
(en)
|
1995-03-06 |
2000-12-26 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions
|
US6187757B1
(en)
|
1995-06-07 |
2001-02-13 |
Ariad Pharmaceuticals, Inc. |
Regulation of biological events using novel compounds
|
US6506379B1
(en)
|
1995-06-07 |
2003-01-14 |
Ariad Gene Therapeutics, Inc. |
Intramuscular delivery of recombinant AAV
|
WO1996041865A1
(en)
|
1995-06-07 |
1996-12-27 |
Ariad Gene Therapeutics, Inc. |
Rapamcycin-based regulation of biological events
|
US5741683A
(en)
|
1995-06-07 |
1998-04-21 |
The Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
US6093570A
(en)
|
1995-06-07 |
2000-07-25 |
The University Of North Carolina At Chapel Hill |
Helper virus-free AAV production
|
US5811524A
(en)
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
ATE465149T1
(de)
|
1996-02-28 |
2010-05-15 |
Ariad Pharma Inc |
Synthetische rapamycinderivate als multimerisierende wirkstoffe für chimere proteine mit von immunophilin abgeleiteten domänen
|
US6723531B2
(en)
|
1996-04-05 |
2004-04-20 |
The Salk Institute For Biological Studies |
Method for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
EP0937082A2
(en)
|
1996-07-12 |
1999-08-25 |
Ariad Pharmaceuticals, Inc. |
Materials and method for treating or preventing pathogenic fungal infection
|
EP1591541B1
(en)
|
1997-04-01 |
2012-02-15 |
Illumina Cambridge Limited |
Method of nucleic acid sequencing
|
ES2224375T3
(es)
|
1997-04-14 |
2005-03-01 |
Cell Genesys, Inc. |
Metodos para aumentar la eficacia del producto de aav recombinante.
|
JP2003524368A
(ja)
|
1997-08-26 |
2003-08-19 |
アリアド ジーン セラピューティクス インコーポレイテッド |
ニ量化ドメイン、三量化ドメインまたは四量化ドメインおよび補足的非相同転写活性化ドメイン、転写抑制ドメイン、dna結合ドメインまたはリガンド結合ドメインを含む融合蛋白
|
US6479653B1
(en)
|
1997-08-26 |
2002-11-12 |
Ariad Gene Therapeutics, Inc. |
Compositions and method for regulation of transcription
|
US6015709A
(en)
|
1997-08-26 |
2000-01-18 |
Ariad Pharmaceuticals, Inc. |
Transcriptional activators, and compositions and uses related thereto
|
EP1003886A1
(en)
|
1997-08-27 |
2000-05-31 |
Ariad Gene Therapeutics, Inc. |
Chimeric transcriptional activators and compositions and uses related thereto
|
JP2002508971A
(ja)
|
1998-01-15 |
2002-03-26 |
アリアド・ジーン・セラピューティクス・インコーポレーテッド |
多量体キメラ蛋白質を使用する生物学的イベントの調節
|
JP2002503667A
(ja)
|
1998-02-13 |
2002-02-05 |
プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ |
新規な二量体化剤、その製造および使用
|
US6984635B1
(en)
|
1998-02-13 |
2006-01-10 |
Board Of Trustees Of The Leland Stanford Jr. University |
Dimerizing agents, their production and use
|
US6333318B1
(en)
|
1998-05-14 |
2001-12-25 |
The Salk Institute For Biological Studies |
Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
EP1080218A1
(en)
|
1998-05-27 |
2001-03-07 |
University of Florida |
Method of preparing recombinant adeno-associated virus compositions by using an iodixanol gradient
|
US6258603B1
(en)
|
1998-06-17 |
2001-07-10 |
Rohm And Haas Company |
Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
US6210892B1
(en)
|
1998-10-07 |
2001-04-03 |
Isis Pharmaceuticals, Inc. |
Alteration of cellular behavior by antisense modulation of mRNA processing
|
US6221349B1
(en)
|
1998-10-20 |
2001-04-24 |
Avigen, Inc. |
Adeno-associated vectors for expression of factor VIII by target cells
|
US6200560B1
(en)
|
1998-10-20 |
2001-03-13 |
Avigen, Inc. |
Adeno-associated virus vectors for expression of factor VIII by target cells
|
US7109317B1
(en)
|
1998-11-06 |
2006-09-19 |
President And Fellows Of Harvard College |
FK506-based regulation of biological events
|
WO2000028004A1
(en)
|
1998-11-10 |
2000-05-18 |
The University Of North Carolina At Chapel Hill |
Virus vectors and methods of making and administering the same
|
ES2478635T3
(es)
|
1999-08-09 |
2014-07-22 |
Targeted Genetics Corporation |
Incremento de la expresión de una secuencia de nucleótidos heteróloga monocatenaria de vectores virales recombinantes diseñando la secuencia de modo que forma pares de bases intracatenarios
|
DE60010098T2
(de)
|
1999-08-24 |
2005-03-31 |
Ariad Gene Therapeutics, Inc., Cambridge |
28-epirapaloge
|
US6780639B1
(en)
|
1999-08-24 |
2004-08-24 |
Universite Libre De Bruxelles |
Antibiotic inducible/repressible genetic construct for gene therapy or gene immunization
|
US7067526B1
(en)
|
1999-08-24 |
2006-06-27 |
Ariad Gene Therapeutics, Inc. |
28-epirapalogs
|
JP3961737B2
(ja)
|
2000-02-29 |
2007-08-22 |
株式会社小糸製作所 |
車両用灯具およびその製造方法
|
MXPA02009157A
(es)
|
2000-03-22 |
2004-04-05 |
Rohm & Haas |
Nuevo sistema de expresion genetica inducible a base del receptor de ecdisona.
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
AU2001268149B2
(en)
|
2000-06-01 |
2005-08-18 |
University Of North Carolina At Chapel Hill |
Methods and compounds for controlled release of recombinant parvovirus vectors
|
US8105825B2
(en)
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
US9249207B2
(en)
|
2001-02-20 |
2016-02-02 |
Intrexon Corporation |
Substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system
|
US7531326B2
(en)
|
2001-02-20 |
2009-05-12 |
Intrexon Corporation |
Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system
|
MXPA03007493A
(es)
|
2001-02-20 |
2004-10-15 |
Rheogene Holdings Inc |
Nuevo sistema de expresion genetica inducible a base de receptor de ecdisona/receptor x retinoide de invertebrado.
|
EP2275558B1
(en)
|
2001-02-20 |
2018-11-28 |
Intrexon Corporation |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
EP1392868B2
(en)
|
2001-05-18 |
2013-09-04 |
Wisconsin Alumni Research Foundation |
Method for the synthesis of dna sequences using photo-labile linkers
|
DE60209193T2
(de)
|
2001-11-13 |
2006-09-28 |
Trustees Of The University Of Pennsylvania |
Verfahren zur Identifizierung von Adeno-assoziiertem Virus (AAV) Sequenzen sowie Kit zur Ausführung der Methode
|
PT2359869T
(pt)
|
2001-12-17 |
2019-04-16 |
Univ Pennsylvania |
Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas
|
WO2003104413A2
(en)
|
2002-06-05 |
2003-12-18 |
University Of Florida |
Production of pseudotyped recombinant aav virions
|
US8005620B2
(en)
|
2003-08-01 |
2011-08-23 |
Dna Twopointo Inc. |
Systems and methods for biopolymer engineering
|
EP1660970A4
(en)
|
2003-08-01 |
2007-02-14 |
Dna Twopointo Inc |
SYSTEMS AND METHODS FOR BIOPOLYMER TECHNOLOGY
|
CN102199626B
(zh)
|
2003-09-30 |
2015-06-24 |
宾夕法尼亚大学托管会 |
腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
|
US20060246079A1
(en)
|
2003-11-14 |
2006-11-02 |
Morrow Phillip R |
Neutralizing human antibodies to anthrax toxin
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
US7838657B2
(en)
|
2004-12-03 |
2010-11-23 |
University Of Massachusetts |
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences
|
ES2525067T3
(es)
|
2005-04-07 |
2014-12-17 |
The Trustees Of The University Of Pennsylvania |
Método de incremento de la función de un vector de AAV
|
WO2006119458A1
(en)
|
2005-05-02 |
2006-11-09 |
Genzyme Corporation |
Gene therapy for neurometabolic disorders
|
JP4495210B2
(ja)
|
2005-06-09 |
2010-06-30 |
パナソニック株式会社 |
振幅誤差補償装置及び直交度誤差補償装置
|
WO2007002390A2
(en)
|
2005-06-23 |
2007-01-04 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for modulation of smn2 splicing
|
US8877187B2
(en)
|
2005-07-25 |
2014-11-04 |
Avianax, Llc |
Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
US9198984B2
(en)
|
2006-04-28 |
2015-12-01 |
The Trustees Of The University Of Pennsylvania |
Scalable production method for AAV
|
MX364444B
(es)
|
2006-06-07 |
2019-04-26 |
Genzyme Corp |
Terapia génica para esclerosis lateral amiotrófica y otros trastornos de la médula espinal.
|
SI3146982T1
(sl)
|
2006-10-03 |
2019-11-29 |
Genzyme Corp |
Genska terapija za amiotrofično lateralno sklerozo in druge motnje hrbtenjače
|
EP2126105A4
(en)
|
2007-02-20 |
2010-11-03 |
Anaptysbio Inc |
SOMATIC HYPERPERMUTATION SYSTEMS
|
WO2008110937A2
(en)
|
2007-03-13 |
2008-09-18 |
Humabs Llc |
Antibodies against h5n1 strains of influenza a virus
|
US9217020B2
(en)
|
2007-04-17 |
2015-12-22 |
National Research Council Of Canada |
Constructs for enhancement of gene expression in muscle
|
US7879326B2
(en)
|
2007-06-15 |
2011-02-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Human neutralizing monoclonal antibodies to H5N1 influenza A virus
|
US8057796B2
(en)
|
2007-11-12 |
2011-11-15 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
WO2009079259A2
(en)
|
2007-12-06 |
2009-06-25 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against influenza virus and methods of use thereof
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
EP2274334A2
(en)
|
2008-03-28 |
2011-01-19 |
Sea Lane Biotechnologies,llc. |
Neutralizing molecules to viral antigens
|
ITTO20080398A1
(it)
|
2008-05-27 |
2009-11-28 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
|
WO2010044921A2
(en)
|
2008-06-03 |
2010-04-22 |
Vaxin Inc. |
Intranasal administration of receptor-binding ligands or genes encoding such ligands as a therapeutic regimen for mitigating infections caused by respiratory pathogens
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
NZ590890A
(en)
|
2008-07-25 |
2013-05-31 |
Inst Research In Biomedicine |
Neutralizing anti-influenza a virus antibodies and uses thereof
|
WO2010053572A2
(en)
|
2008-11-07 |
2010-05-14 |
Massachusetts Institute Of Technology |
Aminoalcohol lipidoids and uses thereof
|
US8211631B2
(en)
|
2008-12-18 |
2012-07-03 |
Wisconsin Alumni Research Foundation |
In vitro model of spinal muscular atrophy
|
RS62779B1
(sr)
|
2009-05-02 |
2022-01-31 |
Genzyme Corp |
Genska terapija neurodegenerativnih poremećaja
|
SG176003A1
(en)
|
2009-05-11 |
2011-12-29 |
Crucell Holland Bv |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
IT1395961B1
(it)
|
2009-06-01 |
2012-11-02 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv)
|
HUE039741T2
(hu)
|
2009-06-17 |
2019-01-28 |
Biogen Ma Inc |
Készítmények és módszerek az SMN2 splicing módosítására egy alanynál
|
AU2010266078B2
(en)
|
2009-06-25 |
2014-08-14 |
Medimmune, Llc |
Swine influenza hemagglutinin variants
|
US8598331B2
(en)
|
2009-09-28 |
2013-12-03 |
The University Of British Columbia |
CLDN5 mini-promoters
|
AU2011238708B2
(en)
|
2010-03-29 |
2016-02-11 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically Induced Transgene Ablation system
|
US9315825B2
(en)
|
2010-03-29 |
2016-04-19 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
US8865881B2
(en)
|
2011-02-22 |
2014-10-21 |
California Institute Of Technology |
Delivery of proteins using adeno-associated virus (AAV) vectors
|
WO2012145572A1
(en)
|
2011-04-20 |
2012-10-26 |
The Trustees Of The University Of Pennsylvania |
Regimens and compositions for aav-mediated passive immunization of airborne pathogens
|
WO2012145759A2
(en)
|
2011-04-21 |
2012-10-26 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Methods of protein production and compositions thereof
|
KR20240135871A
(ko)
|
2011-06-08 |
2024-09-12 |
샤이어 휴먼 지네틱 테라피즈 인크. |
Mrna 전달을 위한 지질 나노입자 조성물 및 방법
|
FR2977562B1
(fr)
|
2011-07-06 |
2016-12-23 |
Gaztransport Et Technigaz |
Cuve etanche et thermiquement isolante integree dans une structure porteuse
|
MX346206B
(es)
|
2011-07-14 |
2017-03-09 |
Crucell Holland Bv |
Moleculas de enlace humanas capaces de neutralizar los virus de la influenza a del grupo filogenetico 1 y grupo filogenetico 2 y virus de la influenza b.
|
WO2013114885A1
(en)
|
2012-01-31 |
2013-08-08 |
Osaka University |
Human monoclonal antibodies broadly protective against influenza b virus and methods of using the same
|
KR102050615B1
(ko)
|
2012-03-08 |
2019-11-29 |
얀센 백신스 앤드 프리벤션 비.브이. |
인플루엔자 b 바이러스들에 결합하고 중화할 수 있는 인간 결합 분자 및 그 용도
|
WO2013151663A1
(en)
*
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of membrane proteins
|
WO2013155222A2
(en)
|
2012-04-10 |
2013-10-17 |
The Regents Of The University Of California |
Brain-specific enhancers for cell-based therapy
|
SG11201406776TA
(en)
|
2012-04-18 |
2015-03-30 |
Philadelphia Children Hospital |
Composition and methods for highly efficient gene transfer using aav capsid variants
|
BR112014029807A2
(pt)
|
2012-06-08 |
2017-06-27 |
Ethris Gmbh |
administração pulmonar de rna mensageiro
|
EP2864488A1
(en)
|
2012-06-21 |
2015-04-29 |
Association Institut de Myologie |
Widespread gene delivery of gene therapy vectors
|
PL2880053T3
(pl)
|
2012-08-01 |
2021-01-11 |
Ikaika Therapeutics, Llc |
Łagodzenie uszkodzenia tkanek i włóknienia przez przeciwciało przeciwko ltbp4
|
US9719106B2
(en)
|
2013-04-29 |
2017-08-01 |
The Trustees Of The University Of Pennsylvania |
Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
|
CA2911105A1
(en)
*
|
2013-05-01 |
2014-11-06 |
Genzyme Corporation |
Compositions and methods for treating spinal muscular atrophy
|
MX2016001026A
(es)
|
2013-07-26 |
2016-08-03 |
Univ Iowa Res Found |
Metodos y composiciones para tratar enfermedades del cerebro.
|
EA201690588A1
(ru)
*
|
2013-10-22 |
2016-09-30 |
Шир Хьюман Дженетик Терапис, Инк. |
Доставка мрнк в цнс и ее применение
|
EP3060669A1
(en)
|
2013-10-24 |
2016-08-31 |
uniQure IP B.V. |
Aav-5 pseudotyped vector for gene therapy for neurological diseases
|
CA2939200A1
(en)
|
2014-02-19 |
2015-08-27 |
Jody Berry |
Ebola monoclonal antibodies
|
US10780182B2
(en)
|
2014-04-25 |
2020-09-22 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for treating metastatic breast cancer and other cancers in the brain
|
US11555059B2
(en)
|
2014-04-25 |
2023-01-17 |
The Trustees Of The University Of Pennsylvania |
LDLR variants and their use in compositions for reducing cholesterol levels
|
US10746742B2
(en)
*
|
2014-04-25 |
2020-08-18 |
Oregon Health & Science University |
Methods of viral neutralizing antibody epitope mapping
|
EA034355B1
(ru)
|
2014-05-02 |
2020-01-30 |
Джензим Корпорейшн |
Векторы на основе aav для генной терапии в сетчатке и cns
|
MY186389A
(en)
|
2014-05-13 |
2021-07-22 |
Univ Pennsylvania |
Compositions comprising aav expressing dual antibody constructs and uses thereof
|
PL3198018T3
(pl)
|
2014-09-24 |
2021-07-19 |
City Of Hope |
Warianty wektora wirusa związanego z adenowirusami dla wysokiej skuteczności edycji genomu i jego sposoby
|
AU2015327819B2
(en)
|
2014-10-03 |
2021-07-01 |
Massachusetts Institute Of Technology |
Antibodies that bind ebola glycoprotein and uses thereof
|
KR20170107562A
(ko)
|
2015-02-05 |
2017-09-25 |
얀센 백신스 앤드 프리벤션 비.브이. |
인플루엔자 적혈구응집소에 대한 결합 분자 및 이의 용도
|
EA201792500A1
(ru)
|
2015-05-13 |
2018-04-30 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Aav-опосредованная экспрессия антител против гриппа и способы их использования
|
CN108779167A
(zh)
|
2015-10-28 |
2018-11-09 |
宾夕法尼亚州大学信托人 |
鞘内施用腺伴随病毒载体用于基因治疗
|
EP3387138B1
(en)
|
2015-12-11 |
2022-01-26 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav9
|
ES2918998T3
(es)
|
2015-12-11 |
2022-07-21 |
Univ Pennsylvania |
Método de purificación escalable para AAVrh10
|
WO2017100674A1
(en)
|
2015-12-11 |
2017-06-15 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav1
|
EP3387117B1
(en)
|
2015-12-11 |
2022-11-23 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav8
|
WO2017106326A1
(en)
|
2015-12-14 |
2017-06-22 |
The Trustees Of The University Of Pennsylvania |
Aav-anti pcsk9 antibody constructs and uses thereof
|
AU2016370630B2
(en)
|
2015-12-14 |
2023-04-13 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated viral vectors useful in treatment of spinal muscular atropy
|
US20190002915A1
(en)
|
2015-12-14 |
2019-01-03 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for regulatable antibody expression
|
SG11201806270XA
(en)
|
2016-02-03 |
2018-08-30 |
Univ Pennsylvania |
Gene therapy for treating mucopolysaccharidosis type i
|
KR102425289B1
(ko)
|
2016-08-15 |
2022-07-27 |
젠자임 코포레이션 |
Aav의 검출 방법
|
US20190240328A1
(en)
|
2016-09-24 |
2019-08-08 |
The Trustees Of The University Of Pennsylvania |
Novel humanized anti-ebola antibodies useful in preventing ebola infections
|
MX2019010275A
(es)
|
2017-02-28 |
2019-10-15 |
Univ Pennsylvania |
Novedoso vector del subtipo f del virus adenoasociado (aav) y usos de este.
|
EP3589649A1
(en)
|
2017-02-28 |
2020-01-08 |
The Trustees Of The University Of Pennsylvania |
Influenza vaccines based on aav vectors
|